We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

1 hedge funds and large institutions have $4.58M invested in Seelos Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $3.62M → $4.58M (+$957K)

0% more funds holding

Funds holding: 1 → 1 (0)

86% less call options, than puts

Call options by funds: $74K | Put options by funds: $543K

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$74K
Puts
$543K
Net Calls
-$469K
Net Calls Change
-$126K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
Rotella Capital Management
Washington
-$31K
2
Wells Fargo
Wells Fargo
California
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.43M – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$689K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$334K – – –
BFA
4
BlackRock Fund Advisors
California
$280K – – –
Northern Trust
5
Northern Trust
Illinois
$132K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$131K – – –
Group One Trading
7
Group One Trading
Illinois
$104K – – –
RG
8
Rathbones Group
United Kingdom
$93K – – –
Deutsche Bank
9
Deutsche Bank
Germany
$49K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$45K – – –
Morgan Stanley
11
Morgan Stanley
New York
$39K – – –
WA
12
WFG Advisors
Texas
$37K – – –
GC
13
Guggenheim Capital
Illinois
$35K – – –
VKH
14
Virtu KCG Holdings
New York
$34K – – –
BA
15
BlackRock Advisors
Delaware
$30K – – –
State Street
16
State Street
Massachusetts
$30K – – –
SM
17
Sabby Management
Florida
$28K – – –
AIG
18
American International Group
New York
$16.2K – – –
Citigroup
19
Citigroup
New York
$16K – – –
U
20
UBS
Switzerland
$9K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$6K – – –
TRCT
22
Tower Research Capital (TRC)
New York
$5K – – –
Bank of America
23
Bank of America
North Carolina
$3K – – –
HDIM
24
Hanson & Doremus Investment Management
Vermont
$3K – – –
HI
25
Hudock Inc
Pennsylvania
$1K – – –
1
2

SEEL Hedge Fund Activity: Q4 2013 in Review

1 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q4 2013, worth a combined $4.58M — up 26% from $3.62M a quarter earlier.

Fund positioning in SEEL was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Rotella Capital Management, cutting an estimated $31K.

  • 1 institutional investor held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $4.58M of Seelos Therapeutics, Inc. Common Stock stock for Q4 2013, up 26% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q4 2013 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q4 2013 was Rotella Capital Management, an estimated $31K sold.

Based on aggregated 13F filings for Q4 2013.